The Rise of Early-onset Cancers: Leading Hypotheses and Emerging Opportunities
Elizabeth M. Jaffee, Timothy R. Rebbeck, and Andrea Cercek spoke about the AACR's conference on the rise of early-onset...
Tag: AACR conferences
Elizabeth M. Jaffee, Timothy R. Rebbeck, and Andrea Cercek spoke about the AACR's conference on the rise of early-onset...
Dan Theodorescu and Lars Dyrskjøt preview the AACR's upcoming conference on bladder cancer.
For the sixth time since 2015, researchers, clinicians, drug developers, patient advocates, and other stakeholders convened at the International...
Factors such as a dense tumor microenvironment, a lack of precise symptoms, and hard-to-target genetic mutations make pancreatic cancer...
Guest post by Patrick Tan, MD, PhD From November 1-3, 2021, Singapore will hold its 13th Frontiers in Cancer...
Most scientists, regardless of field or career stage, have faced difficulties networking and disseminating their research in the past year, with many conferences and symposia canceled. The...
“These are extraordinary times,” began Hugh Auchincloss, MD, as he opened up the recent NIH-AACR Cancer, Autoimmunity, and Immunology...
The advent of immunotherapy has led to durable responses for an increasing number of patients, including many who initially...
Immunotherapeutic advances have dramatically changed the treatment landscape for a host of different cancer types. Notably, immune checkpoint inhibitors...
Lung cancer – one of the most commonly diagnosed cancers in the United States – is an area of...